| | |
| Business | |
| NEWS | |
| Apple's China Nightmare Just Got Much Worse Apple has found itself in a PR nightmare in recent days, with the tech giant's troubled relationship with China thrust into an unwelcoming media spotlight. What began as a little trouble in big China—the withdrawal of an app that let Hong Kong's citizens track ... | |
| Aramco hopes to repair remaining damage from attacks by end-Nov KHURAIS FIELD, Saudi Arabia, Oct 12 (Reuters) - Oil major Saudi Aramco hopes to fix by the end of November the last four key pieces of equipment damaged during attacks last month, in a move to allow it to fully regain production capacity, company officials ... | |
| The Best Mattresses for Couples 2019 There is a period of time in my marriage that my husband and I refer to as "Mattressgate." We had recently moved to a bigger apartment, and we were about to make the life-changing switch from sleeping in a queen-size bed to a king size bed, and we needed ... | |
| | |
| Better Marijuana Stock: Scotts Miracle-Gro vs. Supreme Cannabis Which stock wins in a matchup between a top ancillary provider to the cannabis industry and a small Canadian cannabis producer? Keith Speights. Oct 12, 2019 at 7:00AM. Picks and shovels versus pure play. U.S. versus Canada. Large cap versus small cap. | |
| Why each Libra member's mutiny hurts Facebook There's a strategic cost to the defection of Visa, Stripe, eBay, and more from the Facebook-led cryptocurrency Libra Association. They're not just names dropping off a list. Each potentially made Libra more useful, ubiquitous, or reputable. Now they could ... | |
| 3 Cannabis Stocks That May Not Be Profitable Until 2022 Legal marijuana has been touted as one of the greatest growth trends of our generation, and between 2016 and the first quarter of 2019 it certainly lived up to that billing. With the potential for up to $200 billion in annual sales on the horizon, investors piled ... | |
| Better Buy: Gilead Sciences vs. Johnson & Johnson Gilead Sciences (NASDAQ:GILD) and Johnson & Johnson (NYSE:JNJ) have competed against each other for years in the HIV market. The clear winner in that battle has been Gilead. J&J could also soon have Gilead nipping at its heels in the immunology ... | |
| Facebook's Libra currency battered by defections, pushback Visa, MasterCard, eBay, PayPal and Stripe have all dropped out of the Facebook's Libra currency project. AP. By. AssociatedPress. Facebook faces a rough road ahead with Libra, but defections by high-profile partners are still unlikely to spell the end for the ... | |
| Marijuana Madness Turns Into a Cannabis Crash The party is over for cannabis companies. Share prices of marijuana producers tumbled this week, some by nearly 40%, after a string of disappointing quarterly reports and mounting skepticism about the industry's rosy growth forecasts. Among the news this ... | |
See more results | Edit this alert |
Tidak ada komentar:
Posting Komentar